IMMP Immutep Limited - American Depositary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Oct 24, 2025
$4.35
· of 52w range
· above low
· to high
$4.1752w low
$70.6052w high
P/E
-38.9
EPS
$-0.04
Revenue
$10M
your badges
52W Range
$4–$71
Analyst Rating
HOLD
Price Target
$30
P/E
-38.9
ROE
-36.9%
Net Profit Margin
-594.6%
Your badge strip is empty — pin a metric anywhere on this page.
IMMP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.35
P/E
-38.9
EPS
$-0.04
Revenue
$10M
ROE
-36.9%
52W Range
$4–$71
IMMP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Sept. 28, 2026 | 1-for-20 | Reverse |
| Dec. 28, 2016 | 1-for-3 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$10M2016-06-30 → 2025-06-30
EPS$-0.042016-06-30 → 2025-06-30
Free Cash Flow$-62M2018-06-30 → 2025-06-30
Net margin-594.6%2018-06-30 → 2025-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | IMMP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -38.95Y avg ≈-54.6 | ≈-54.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | IMMP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| EBITDA Margin | 23.1%5Y avg ≈34.9% | ≈34.9% | · | · | |
| Pretax Margin | -594.6%5Y avg ≈-627.4% | ≈-627.4% | · | · | |
| Net Profit Margin | -594.6%5Y avg ≈-627.4% | ≈-627.4% | · | · | |
| ROA | -34.3%5Y avg ≈-34.4% | ≈-34.4% | · | · | |
| ROE | -36.9%5Y avg ≈-38.5% | ≈-38.5% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | IMMP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 11.75Y avg ≈14.1 | ≈14.1 | · | · | |
| Quick Ratio | 6.15Y avg ≈12.4 | ≈12.4 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | IMMP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.1 | ≈0.1 | · | · | |
| Receivables Turnover | 1.25Y avg ≈0.9 | ≈0.9 | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
6.4%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.02 | $0.00 | — | |
| Dec. 31, 2025 | $-0.03 | $-0.03 | -9.9% | |
| June 30, 2025 | $-0.03 | $-0.03 | 1.1% | |
| Dec. 31, 2024 | $-0.01 | $-0.02 | 30.6% | |
| June 30, 2024 | $-0.02 | $-0.02 | 3.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $8M | $5M | $7M | $4M | $16M | $7M | $7M | $4M | |
| R&D Expense | $50M | $31M | $29M | $25M | $12M | $16M | $14M | $10M | $8M | |
| SG&A Expense | $9M | $9M | $9M | $7M | $6M | $6M | $6M | $7M | $4M | |
| Interest Expense | $37.1K | $30.6K | $20.4K | $92.4K | $9.8K | $10.5K | $0 | · | · | |
| Interest Income | $5M | $4M | $939.0K | $224.5K | $105.3K | $199.5K | $397.3K | $177.2K | $104.4K | |
| Pretax Income | $-61M | $-43M | $-40M | $-32M | $-30M | $-13M | $-18M | $-13M | $-10M | |
| Income Tax | $0 | $0 | $0 | $34 | $33 | $37 | $0 | $1.7K | $-737.4K | |
| Net Income | $-61M | $-43M | $-40M | $-32M | $-30M | $-13M | $-18M | $-13M | $-9M | |
| EPS (Basic) | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.03 | $-5.29 | $-4.63 | $-0.40 | |
| EPS (Diluted) | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.03 | $-5.29 | $-4.63 | $-0.40 | |
| Shares (Basic) | 1,455,818,442 | 1,201,061,930 | 892,399,810 | 848,968,068 | 594,927,440 | 412,855,961 | 346,805,822 | 275,103,115 | 2,370,387,786 | |
| Shares (Diluted) | 1,455,818,442 | 1,201,061,930 | 892,399,810 | 848,968,068 | 594,927,440 | 412,855,961 | 346,805,822 | 275,103,115 | 2,370,387,786 | |
| EBITDA | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $67M | $162M | $123M | $80M | $61M | $26M | $17M | $23M | $12M | |
| Receivables | $10M | $7M | $8M | $8M | $6M | $3M | $5M | $3M | $2M | |
| Current Assets | $149M | $191M | $135M | $91M | $68M | $31M | $24M | $29M | $16M | |
| PP&E (Net) | $63.5K | $63.1K | $83.1K | $37.9K | $40.9K | $49.4K | $53.0K | $26.4K | $24.2K | |
| Total Assets | $157M | $202M | $147M | $102M | $82M | $47M | $41M | $47M | $35M | |
| Accounts Payable | $11M | $10M | $9M | $6M | $5M | $3M | $5M | $4M | $3M | |
| Current Liabilities | $13M | $10M | $10M | $6M | $5M | $3M | $5M | $4M | $3M | |
| Total Liabilities | $13M | $12M | $11M | $8M | $9M | $13M | $16M | $13M | $8M | |
| Retained Earnings | $-444M | $-383M | $-340M | $-302M | $-275M | $-276M | $-262M | $-245M | $-232M | |
| Stockholders' Equity | $144M | $190M | $136M | $94M | $73M | $33M | $24M | $34M | $27M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | $-3M | $6M | $2M | $-82.4K | $10M | $549.3K | $1M | $3M | · | |
| Operating Cash Flow | $-62M | $-35M | $-35M | $-30M | $-18M | $-11M | $-15M | $-8M | $-9M | |
| CapEx | $45.8K | $29.2K | $82.7K | $22.9K | $15.6K | $19.3K | $41.4K | $11.9K | $6.6K | |
| Investing Cash Flow | $-39M | $-21M | $-82.7K | $-22.9K | $-15.6K | $-19.3K | $-41.4K | $-11.9K | $-6.6K | |
| Financing Cash Flow | $-525.1K | $95M | $76M | $50M | $53M | $20M | $8M | $18M | $-8.5K | |
| Free Cash Flow | $-62M | $-35M | $-35M | $-30M | $-18M | $-11M | $-15M | $-8M | · | |
| Levered FCF | $-62M | $-35M | $-35M | $-30M | $-18M | $-11M | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -594.6% | -544.9% | -767.2% | -476.6% | -753.6% | -81.6% | -244.9% | -173.3% | · | |
| Pretax Margin | -594.6% | -544.9% | -767.2% | -476.6% | -753.6% | -81.6% | -244.9% | -173.3% | · | |
| EBITDA Margin | 23.1% | 28.9% | 39.6% | 30.5% | 52.2% | 12.6% | 25.1% | 24.6% | · | |
| ROA | -34.3% | -24.5% | -32.0% | -35.0% | -46.5% | -30.9% | -41.9% | -31.1% | · | |
| ROE | -36.9% | -26.2% | -34.6% | -38.5% | -56.1% | -46.7% | -63.3% | -42.4% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | 18.2 | 13.8 | 14.2 | 12.8 | 9.3 | 4.4 | 7.4 | · | |
| Quick Ratio | 6.1 | 16.1 | 13.4 | 13.8 | 12.5 | 8.8 | 4.1 | 7.0 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.4 | 0.2 | 0.2 | · | |
| Receivables Turnover | 1.2 | 1.0 | 0.6 | 0.9 | 0.8 | 3.9 | 1.7 | 2.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.04 | $0.00 | $0.00 | · | |
| Cash Flow / Share | $-0.04 | $-0.03 | $-0.04 | $-0.04 | $-0.03 | $-0.03 | $-0.00 | $-0.00 | · | |
| EPS (TTM) | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.03 | $-5.29 | $-4.63 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $8M | $5M | $7M | $4M | $16M | $7M | $7M | · | |
| Net Income TTM | $-61M | $-43M | $-40M | $-32M | $-30M | $-13M | $-18M | $-13M | · | |
| P/E | -38.9 | -56.5 | -47.2 | -53.6 | -76.9 | -33.1 | -0.3 | -0.5 | · | |
| Earnings Yield | -2.6% | -1.8% | -2.1% | -1.9% | -1.3% | -3.0% | -290.7% | -194.5% | · |
Per Share
| Metric | Trend | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-0.40 | $-2.78 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $2M | · | · | · | · | |
| Net Income TTM | $-9M | $-62M | · | · | · | · | |
| P/E | -5.4 | -1.2 | · | · | · | · | |
| Earnings Yield | -18.5% | -86.0% | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Revenue | $10M | $8M | $5M | $7M | $4M |
| Net Income | $-61M | $-43M | $-40M | $-32M | $-30M |
| Diluted EPS | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.05 |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Current Ratio | 11.7 | 18.2 | 13.8 | 14.2 | 12.8 |
| Quick Ratio | 6.1 | 16.1 | 13.4 | 13.8 | 12.5 |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $-62M | $-35M | $-35M | $-30M | $-18M |
Institutional owners (13F) 25 filers · $739K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
25
Value held
$739K
New positions
12
Exited positions
12
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 12 (0 vs prior Q) | 12 (+3 vs prior Q) | 3 (-2 vs prior Q) | 8 (-1 vs prior Q) | -829K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $308,993 | 741,167 | 41.81% | Shares |
| Vanguard Personalized Indexing Management, LLC | $149,537 | 358,688 | 20.24% | Shares |
| CITADEL ADVISORS LLC | $71,623 | 171,800 | 9.69% | Call option |
| MARSHALL WACE, LLP | $36,867 | 87,778 | 4.99% | Shares |
| TWO SIGMA INVESTMENTS, LP | $32,155 | 77,130 | 4.35% | Shares |
| Mariner, LLC | $29,436 | 70,606 | 3.98% | Shares |
| XTX Topco Ltd | $19,629 | 47,083 | 2.66% | Shares |
| CITIGROUP INC | $17,629 | 42,285 | 2.39% | Shares |
| HBK Sorce Advisory LLC | $15,146 | 38,617 | 2.05% | Shares |
| LPL Financial LLC | $14,167 | 33,982 | 1.92% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11,560 | 27,729 | 1.56% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $10,885 | 26,109 | 1.47% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $5,541 | 13,292 | 0.75% | Shares |
| Tower Research Capital LLC (TRC) | $4,218 | 10,119 | 0.57% | Shares |
| US BANCORP \DE\ | $4,066 | 9,750 | 0.55% | Shares |
| SIMPLEX TRADING, LLC | $3,274 | 7,852 | 0.44% | Shares |
| CVA Family Office, LLC | $1,105 | 2,650 | 0.15% | Shares |
| ROYAL BANK OF CANADA | $1,000 | 2,932 | 0.14% | Shares |
| SBI Securities Co., Ltd. | $835 | 2,002 | 0.11% | Shares |
| MORGAN STANLEY | $628 | 1,507 | 0.08% | Shares |
| EverSource Wealth Advisors, LLC | $462 | 1,108 | 0.06% | Shares |
| BARCLAYS PLC | $163 | 391 | 0.02% | Shares |
| UBS Group AG | $58 | 138 | 0.01% | Shares |
| Virtu Financial LLC | $9 | 22,718 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $0 | 1 | 0.00% | Shares |
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IBB · iShares Trust | 0.00% | 781,818 SH | Sept. 11, 2026 | Daily |
IMMP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$30.00
+589.7%
1 12.5%
Strong Buy
3 37.5%
Buy
4 50.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-29Mean target $30.00 +589.7%
Low$30.00
Mean$30.00
High$30.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| IMMP | · | -38.9 | · | -594.6% | -36.9% | · |
| KZIA | · | -165.9 | · | -49290.5% | 226.0% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Oct 24, 2025